About Mythic Therapeutics
Mythic Therapeutics is a private company based in Waltham, Massachusetts. It has reported $53,468,045 raised in three offerings on Form D since August 2020. Its chief executive is George Eliades.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Dec 9, 2024 | Dec 26, 2024 | $29,868,794of $30.4M target | 30 | $995K | Securities on exerciseRule 506(b) | Form D ↗ |
| Jun 11, 2018 | Aug 14, 2020 | $4,749,262fully sold | 21 | $226K | EquityRule 506(b) | Form D ↗ |
| Jul 31, 2020 | Aug 14, 2020 | $18,849,989fully sold | 18 | $1.0M | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $53,468,045 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Mythic Therapeutics's Form D filed Dec 26, 2024.
GE
George Eliades
Chief Executive Officer and director
BR
Bryan Roberts
Director
PH
Peter Hecht
Director
SP
Sandra Poole
Executive officer
BF
Brian Fiske
Executive officer and director
Earlier filings also listed Josh Kopelman (director, last listed Aug 2020), Jason Hanson (director, last listed Aug 2020) and Alex Nichols (chief executive officer and director, last listed Aug 2020).